ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,641Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 241

$5M Total Retail Price of All Prescriptions

Rank: 2 out of 241

1,904 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

1% of this provider’s 1,904 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

21% of this provider’s 1,904 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

4% of this provider’s 10,242 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$300 was the average price of a prescription from this provider, compared to $175 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
HYDROCODONE-ACETAMINOPHEN 1,257 673 S3 1 3
METHOTREXATE 1,112 653 2 2
GABAPENTIN 960 607 3 6
TRAMADOL HCL 888 583 4 5
PREDNISONE 884 553 5 1
VOLTAREN 765 533 10 6 19
CYCLOBENZAPRINE HCL 703 374 R 10 7 15
HYDROXYCHLOROQUINE SULFATE 619 386 8 4
LYRICA 565 290 9 12
NAPROXEN 486 277 10 28
TRAMADOL HCL-ACETAMINOPHEN 421 343 11 22
LIDODERM 420 283 12 27
ORENCIA 419 333 10 13 38
SULFASALAZINE 418 248 10 14 20
REMICADE 400 210 10 15 56
ALENDRONATE SODIUM 359 293 16 9
MELOXICAM 336 212 17 7
LEFLUNOMIDE 330 198 18 8
CYMBALTA 318 174 19 11
SULFAZINE EC 286 171 10 20 62
DICLOFENAC SODIUM 244 168 21 34
COLCRYS 241 187 22 33
SULFASALAZINE DR 214 113 10 23 47
ENBREL 202 66 24 10
METHYLPREDNISOLONE 187 147 25 23
ULORIC 169 129 26 44
CELEBREX 145 101 27 13
ALLOPURINOL 139 104 28 16
IBUPROFEN 135 51 29 41
PIROXICAM 110 74 30 124
SULFAZINE 104 75 10 31 70
SOLARAZE 103 75 32 129
NEXIUM 102 39 33 31
HYDROCODONE BIT-IBUPROFEN 100 39 S3 34 86
MINOCYCLINE HCL 100 87 34 131
DEXAMETHASONE 91 75 36 134
OMEPRAZOLE 85 50 37 17
FUROSEMIDE 74 53 38 46
HUMIRA 72 29 39 14
NABUMETONE 71 40 40 29
AZATHIOPRINE 69 51 41 26
SAVELLA 62 27 42 58
BACLOFEN 59 29 43 164
TIZANIDINE HCL 54 30 44 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.